(Pyr1)-Urotensin II (rat) features an N-terminal pyroglutamyl residue that enhances resistance to exopeptidase degradation. The cyclic core stabilized by a disulfide bridge supports defined conformation. Its sequence is valuable for receptor-binding and structural studies in rodent systems. Research applications include peptide-receptor interaction analysis and conformational modeling.
CAT No: U03009
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More